Before reviewing, I signed up with MEDVi, recorded the process, and gathered the key info you need to see if its a good fit
March 17, 2026
Research and clinical studies have examined its impact on various health conditions, providing valuable insights
Dual GIP/GLP-1 agonists may be better for patients who havent achieved sufficient weight loss with GLP-1 medications alone, those requiring more aggressive metabolic intervention, individuals who can tolerate the slightly higher side effect rates at maximum doses, and patients seeking the most effective currently available FDA-approved option
However, supplements may not be suitable for those who have: a sensitivity to monosodium glutamate epilepsy bipolar disorder liver disease They may also interfere with antiseizure medications
Half-life is 20-30 hours versus roughly 10 minutes for native IGF-1 which is exactly why vendor quality and reconstitution matter so much